Antalgic Efficacy of CycloMesh™ Soaked in Ropivacaine Hydrochloride in Uncomplicated Inguinal Hernia. (HENRI)
Interventional Study of Antalgic Efficacy of the CycloMesh™ Implant Soaked in Ropivacaine Hydrochloride 10 Mg/mL in the Treatment of Uncomplicated Inguinal Hernia. Randomized Comparative Study Versus CycloMesh™ Soaked in Physiological Saline Solution NaCl 9°/°°
Sponsor: Cousin Biotech
Listed as NCT04033055, this NA trial focuses on Inguinal Hernia and remains completed. Sponsored by Cousin Biotech, it has been updated 9 times since 2019, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Apr 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Apr 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Apr 2023 — Jul 2024 [monthly]
Completed NA
Status: Unknown Status → Completed
-
Oct 2021 — Apr 2023 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
▶ Show 4 earlier versions
-
Jan 2021 — Oct 2021 [monthly]
Recruiting NA
-
Apr 2020 — Jan 2021 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Oct 2019 — Apr 2020 [monthly]
Not Yet Recruiting NA
-
Aug 2019 — Oct 2019 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Cousin Biotech
- Quanta Medical
For direct contact, visit the study record on ClinicalTrials.gov .